Antibody–drug conjugates (ADCs) are targeted immunoconjugate constructs that integrate
the potency of cytotoxic drugs with the selectivity of monoclonal antibodies, minimizing …

Nanobiotechnology, as a novel and more specialized branch of science, has provided a
number of nanostructures such as nanoparticles, by utilizing the methods, techniques, and …

In response to infection or sterile insults, inflammatory programmed cell death is an essential
component of the innate immune response to remove infected or damaged cells …

Objective To assess the efficacy and safety of subcutaneous administration of 30 mg or 80
mg of ozoralizumab plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) …

Background It is highly desirable to develop new therapeutic strategies for gastric cancer
given the low survival rate despite improvement in the past decades. Cadherin 17 (CDH17) …

The development of monoclonal antibody treatments for successful tumor-targeted therapies
took several decades. However, the efficacy of antibody-based therapy is still confined and …

Cancer is one of the most common diseases and causes of death worldwide. Since common
treatment approaches do not yield acceptable results in many patients, developing …

Objective To assess the efficacy and safety through a 52-week treatment with subcutaneous
ozoralizumab at 30 or 80 mg in patients with active rheumatoid arthritis despite methotrexate …

Objectives The aim is to assess the efficacy and safety of a 52-week subcutaneous
ozoralizumab treatment at 30 and 80 mg without methotrexate (MTX) in active rheumatoid …

Biosensing approaches that combine small, engineered antibodies (nanobodies) with
nanoparticles are often complicated. Here, we show that nanobodies with different C …